Collatamp^®

Collatamp, is a lyophilized collagen implant impregnated with the aminoglycoside antibiotic gentamicin. Collatamp is used for local haemostasis of capillary, parenchymatous and seeping haemorrhages in areas with a high risk of infection.

This product contains gentamicin sulphate at a locally effective dose. Collatamp is absorbed quickly and completely, and it is not necessary to remove it. The product can be available with bovine collagen: Collatamp G or with equine collagen Collatamp EG. According to the local regulations, Collatamp is considered as a medical device or as a drug. Collatamp can be available (according to the country) under 3 different presentations: 5 cm x 5 cm; 10 cm x 10 cm and 5 cm x 20 cm.

There are more than 40 clinical studies evaluating the performance of Collatamp®, either for treating localized infection or for preventing surgical site infections across a wide variety of surgical procedures.

Pharmacoeconomic studies have demonstrated that Collatamp leads to reduced treatment expenses and an overall cost saving for the hospital if used routinely. Please contact info@eusapharma.com for further details.

The primary use of the product is for surgeries having a high risk of infection and/or where surgical site infection can lead to severe complications, including:

• Orthopedics (including treatment of bone infections)
• Mixed tissue trauma
• Cardiac surgery
• Vascular surgery
• Rectal extirpation
• Pilonidal sinus
• Abdominal surgery
• Appendectomy

Collatamp is marketed by EUSA in over 30 countries in Europe, North America, Africa and the Middle East under the following tradenames: Collatamp® G, Collatamp® EG, Sulmycin® Implant, Garamycin® Schwamm, Duracoll®, Garacoll®, Garacol®, Gentacoll®, Gentacol® and Cronocol®.

For information on our full range of products, where they are available and prescribing information, please see the Summary table.